Author(s): Byrnes JR, Wolberg AS
Venous thrombosis (VT) is the third most common cause of cardiovascular death worldwide. Complications from VT and pulmonary embolism are the leading cause of lost disability-adjusted life years. Risks include genetic (e.g., non-O blood group, activated protein C resistance, hyperprothrombinemia) and acquired (e.g., age, surgery, cancer, pregnancy, immobilisation, female hormone use) factors. Pathophysiologic mechanisms that promote VT are incompletely understood, but involve abnormalities in blood coagulability, vessel function, and flow (so-called Virchow’s Triad). Epidemiologic studies of humans, animal models, and biochemical and biophysical investigations have revealed contributions from extrinsic, intrinsic, and common pathways of coagulation, endothelial cells, leukocytes, red blood cells, platelets, cell-derived microvesicles, stasis-induced changes in vascular cells, and blood rheology. Knowledge of these mechanisms may yield new therapeutic targets. Characterisation of mechanisms that mediate VT formation and stability, particularly in aging, are needed to advance understanding of VT.
Referred From: https://doi.org/10.5482/HAMO-16-09-0034
Author(s): Kumar S, Sarr MG, Kamath PS
Author(s): Hmoud B, Singal AK, Kamath PS
Author(s): James AW, Rabl C, Westphalen AC, Fogarty PF, Posselt AM, et al.
Author(s): Schmandra TC, Kim ZG, Gutt CN
Author(s): Lindberg F, Rasmussen I, Siegbahn A, Bergqvist D
Author(s): Larsen JF, Ejstrud P, Svendsen F, Redke F, Pedersen V, et al.
Author(s): arsen JF, Ejstrud P, Svendsen F, Redke F, Pedersen V, et al.
Author(s): Schafer M, Krahenbuhl L
Author(s): Schmedt CG, Heupel O, Riemer V, Gutt CN, Büchler MW
Author(s): Rikimaru H
Author(s): Zhang J, Duan ZQ, Song QB, Luo YW, Xin SJ, et al.
Author(s): Rhee RY, Gloviczki P, Mendonca CT, Petterson TM, Serry RD, et al.
Author(s): Van Dijk LJ, Van Petersen AS, Moelker A
Author(s): Bala M, Kashuk J, Moore EE, Kluger Y, Biffl W, et al.